Clinical and laboratory features of patients
| Characteristic . | All patients . | |
|---|---|---|
| n = 74 . | % . | |
| Sex | ||
| Male | 46 | 63 | 
| Female | 28 | 37 | 
| Light-chain type | ||
| κ | 55 | 74 | 
| λ | 18 | 24 | 
| Biclonal | 1 | 2 | 
| B2-microglobulin > 2.7 (mg/L) | 24 of 39 | 62 | 
| Albumin < 3.5 (g/dL) | 23 of 46 | 50 | 
| Labeling index 1* (%) | 1 | 2 | 
| Hemoglobin < 11 | 47 of 73 | 64 | 
| BM clonal involvement (%) | 50 (median) | 5-95 (range) | 
| Characteristic . | All patients . | |
|---|---|---|
| n = 74 . | % . | |
| Sex | ||
| Male | 46 | 63 | 
| Female | 28 | 37 | 
| Light-chain type | ||
| κ | 55 | 74 | 
| λ | 18 | 24 | 
| Biclonal | 1 | 2 | 
| B2-microglobulin > 2.7 (mg/L) | 24 of 39 | 62 | 
| Albumin < 3.5 (g/dL) | 23 of 46 | 50 | 
| Labeling index 1* (%) | 1 | 2 | 
| Hemoglobin < 11 | 47 of 73 | 64 | 
| BM clonal involvement (%) | 50 (median) | 5-95 (range) | 
Includes plasma cells and lymphocyte clonal cells (defined by light-chain restriction).